SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Soul Biotechnology Corp. – ‘10-Q’ for 3/31/23 – ‘EX-101.CAL’

On:  Monday, 5/15/23, at 12:50pm ET   ·   For:  3/31/23   ·   Accession #:  1829126-23-3413   ·   File #:  0-56213

Previous ‘10-Q’:  ‘10-Q’ on 10/21/22 for 9/30/22   ·   Next:  ‘10-Q’ on 9/27/23 for 6/30/23   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    508K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     16K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 9: R1          Cover                                               HTML     59K 
10: R2          Consolidated Balance Sheets (Unaudited)             HTML     95K 
11: R3          Consolidated Balance Sheets (Unaudited)             HTML     22K 
                (Parenthetical)                                                  
12: R4          Consolidated Statements of Operations (Unaudited)   HTML     98K 
13: R5          Consolidated Statements of Changes in               HTML     44K 
                Shareholders' Deficit (Unaudited)                                
14: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     61K 
15: R7          Organization and Description of the Business        HTML     32K 
16: R8          Summary of Significant Accounting Assumptions and   HTML     53K 
                Policies                                                         
17: R9          Going Concern                                       HTML     18K 
18: R10         Business Acquisition                                HTML     36K 
19: R11         Intangible Assets                                   HTML     17K 
20: R12         Related Party Transactions                          HTML     21K 
21: R13         Common Stock and Common Stock Payable               HTML     23K 
22: R14         Subsequent Events                                   HTML     16K 
23: R15         Summary of Significant Accounting Assumptions and   HTML     92K 
                Policies (Policies)                                              
24: R16         Business Acquisition (Tables)                       HTML     31K 
25: R17         Organization and Description of the Business        HTML     31K 
                (Details Narrative)                                              
26: R18         Summary of Significant Accounting Assumptions and   HTML     18K 
                Policies (Details Narrative)                                     
27: R19         Going Concern (Details Narrative)                   HTML     18K 
28: R20         Business Acquisition (Details)                      HTML     19K 
29: R21         Business Acquisition (Details 1)                    HTML     35K 
30: R22         Business Acquisition (Details Narrative)            HTML     28K 
31: R23         Intangible Assets (Details Narrative)               HTML     25K 
32: R24         Related Party Transactions (Details Narrative)      HTML     21K 
33: R25         Common Stock and Common Stock Payable (Details      HTML     42K 
                Narrative)                                                       
36: XML         IDEA XML File -- Filing Summary                      XML     61K 
34: XML         XBRL Instance -- soulbiotechno_10q_htm               XML    322K 
35: EXCEL       IDEA Workbook of Financial Reports                  XLSX     58K 
 5: EX-101.CAL  XBRL Calculations -- adob-20230331_cal               XML     80K 
 6: EX-101.DEF  XBRL Definitions -- adob-20230331_def                XML    141K 
 7: EX-101.LAB  XBRL Labels -- adob-20230331_lab                     XML    408K 
 8: EX-101.PRE  XBRL Presentations -- adob-20230331_pre              XML    321K 
 4: EX-101.SCH  XBRL Schema -- adob-20230331                         XSD     58K 
37: JSON        XBRL Instance as JSON Data -- MetaLinks              202±   285K 
38: ZIP         XBRL Zipped Folder -- 0001829126-23-003413-xbrl      Zip    108K

‘EX-101.CAL’   —   XBRL Calculations — adob-20230331_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://adorbs.com/role/Cover" xlink:href="adob-20230331.xsd#Cover" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BalanceSheets" xlink:href="adob-20230331.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BalanceSheetsParenthetical" xlink:href="adob-20230331.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/StatementsOfOperations" xlink:href="adob-20230331.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="adob-20230331.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/StatementsOfCashFlows" xlink:href="adob-20230331.xsd#StatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="adob-20230331.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPolicies" xlink:href="adob-20230331.xsd#SummaryOfSignificantAccountingAssumptionsAndPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/GoingConcern" xlink:href="adob-20230331.xsd#GoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BusinessAcquisition" xlink:href="adob-20230331.xsd#BusinessAcquisition" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/IntangibleAssets" xlink:href="adob-20230331.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/RelatedPartyTransactions" xlink:href="adob-20230331.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/CommonStockAndCommonStockPayable" xlink:href="adob-20230331.xsd#CommonStockAndCommonStockPayable" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/SubsequentEvents" xlink:href="adob-20230331.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" xlink:href="adob-20230331.xsd#SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BusinessAcquisitionTables" xlink:href="adob-20230331.xsd#BusinessAcquisitionTables" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="adob-20230331.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative" xlink:href="adob-20230331.xsd#SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/GoingConcernDetailsNarrative" xlink:href="adob-20230331.xsd#GoingConcernDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BusinessAcquisitionDetails" xlink:href="adob-20230331.xsd#BusinessAcquisitionDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BusinessAcquisitionDetails1" xlink:href="adob-20230331.xsd#BusinessAcquisitionDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" xlink:href="adob-20230331.xsd#BusinessAcquisitionDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/IntangibleAssetsDetailsNarrative" xlink:href="adob-20230331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="adob-20230331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" xlink:href="adob-20230331.xsd#CommonStockAndCommonStockPayableDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/Cover" xlink:title="00000001 - Document - Cover"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets (Unaudited)">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="adob-20230331.xsd#adob_CommonStockPayable" xlink:label="loc_adobCommonStockPayable"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_adobCommonStockPayable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="adob-20230331.xsd#adob_DueToRelatedParties" xlink:label="loc_adobDueToRelatedParties"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_adobDueToRelatedParties" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaapOtherLongTermDebt"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLongTermDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="adob-20230331.xsd#adob_CommonStockPayables" xlink:label="loc_adobCommonStockPayables"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_adobCommonStockPayables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/GoingConcern" xlink:title="00000009 - Disclosure - GOING CONCERN"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BusinessAcquisition" xlink:title="00000010 - Disclosure - BUSINESS ACQUISITION"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/IntangibleAssets" xlink:title="00000011 - Disclosure - INTANGIBLE ASSETS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/RelatedPartyTransactions" xlink:title="00000012 - Disclosure - RELATED PARTY TRANSACTIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/CommonStockAndCommonStockPayable" xlink:title="00000013 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/SubsequentEvents" xlink:title="00000014 - Disclosure - SUBSEQUENT EVENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BusinessAcquisitionTables" xlink:title="00000016 - Disclosure - BUSINESS ACQUISITION (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="00000017 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/GoingConcernDetailsNarrative" xlink:title="00000019 - Disclosure - GOING CONCERN (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BusinessAcquisitionDetails" xlink:title="00000020 - Disclosure - BUSINESS ACQUISITION (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BusinessAcquisitionDetails1" xlink:title="00000021 - Disclosure - BUSINESS ACQUISITION (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" xlink:title="00000022 - Disclosure - BUSINESS ACQUISITION (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000023 - Disclosure - INTANGIBLE ASSETS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" xlink:title="00000025 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative)"/>
</link:linkbase>

4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/10/22  Soul Biotechnology Corp.          8-K:1,2,3,5 2/10/22   14:1.2M                                   Empire Filings/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA
11/18/20  Soul Biotechnology Corp.          10-12G/A               6:838K                                   EdgarAgents LLC/FA
 1/19/18  Soul Biotechnology Corp.          S-1                    6:1M                                     S2 Filings LLC/FA
↑Top
Filing Submission 0001829126-23-003413   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 11, 9:06:08.1pm ET